Lion Street Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Lion Street Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$526K	Buy	4,212 +64	+2%	+$5.76K	0.18%	107
2025 Q2	$344K	Sell	4,148 -220	-5%	-$17.6K	0.1%	200
2025 Q1	$354K	Sell	4,368 -25	-0.6%	-$2.23K	0.11%	186
2024 Q4	$396K	Buy	4,393 +450	+11%	+$43.6K	0.13%	165
2024 Q3	$390K	Sell	3,943 -300	-7%	-$29.5K	0.14%	167
2024 Q2	$393K	Buy	4,243 +1	+0%	+$90	0.15%	151
2024 Q1	$379K	Hold	4,242	–	–	0.15%	143
2023 Q4	$379K	Sell	4,242 -300	-7%	-$22.3K	0.16%	143
2023 Q3	$332K	Buy	4,542 +320	+8%	+$25.6K	0.11%	163
2023 Q2	$527K	Sell	4,222 -366	-8%	-$30.6K	0.18%	113
2023 Q1	$350K	Buy	4,588 +1,277	+39%	+$106K	0.11%	156
2022 Q4	$413K	Sell	3,311 -105	-3%	-$8.5K	0.22%	75
2022 Q3	$273K	Buy	3,416 +105	+3%	+$8.85K	0.14%	97
2022 Q2	$406K	Sell	3,311 -15	-0.5%	-$1.13K	0.21%	80
2022 Q1	$298K	Sell	3,326 -30	-0.9%	-$2.77K	0.15%	105
2021 Q4	$374K	Buy	3,356 +45	+1%	+$5.43K	0.18%	88
2021 Q3	$417K	Buy	+3,311	New	+$426K	0.23%	73

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Lion Street Advisors's XBI Position: Q3 2025 in Review

Lion Street Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.5% in Q3 2025, buying an estimated $5.76K and bringing the position to 4,212 shares worth $526K. The position accounts for 0.18% of the portfolio, ranked #107.

Lion Street Advisors first reported a position in XBI in Q3 2021 and has held it in 17 quarters since. The position peaked at $527K in Q2 2023. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Lion Street Advisors held 4,212 shares of State Street SPDR S&P Biotech ETF worth $526K as of Q3 2025.
Lion Street Advisors bought 64 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $5.76K.
State Street SPDR S&P Biotech ETF made up 0.18% of Lion Street Advisors's portfolio in Q3 2025, its #107 holding.
Lion Street Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and has held it in 17 quarters since.
Lion Street Advisors's State Street SPDR S&P Biotech ETF position peaked at $527K in Q2 2023.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Lion Street Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.